Krishna Raghavan, MD
![1]()
News
IV drug users: The new face of candidemia
April 28, 2021
Intravenous drug use is an increasingly common risk factor for candidemia as the opioid crisis worsens.
![1]()
News
Thyroid hormone analogues can reverse NASH
April 27, 2021
In patients with nonalcoholic steatohepatitis (NASH) and stages 1-3 fibrosis, does the thyroid hormone receptor beta-agonist, resmetirom reduce hepatic steatosis compared with placebo?
